Clinical Trial Update: Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer

View source ↗

Summary

A clinical trial is currently recruiting to evaluate chemotherapy combined with targeted therapy for high-risk HER2-positive, lymph node-negative early breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shu Wang | Conditions: HER2-positive Breast Cancer | Status: RECRUITING